Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-18 Sale |
2025-03-19 4:03 pm |
Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer |
3,535 | $1.483 | $5,242 | 481,710 (Direct) |
View |
| 2025-02-19 Sale |
2025-02-20 4:50 pm |
Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer |
11 | $1.86 | $20 | 240,671 (Direct) |
View |
| 2025-01-17 Sale |
2025-01-21 4:38 pm |
Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer |
9 | $2.265 | $20 | 240,682 (Direct) |
View |
| 2024-12-17 Sale |
2024-12-18 4:14 pm |
Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer |
3,245 | $2.424 | $7,866 | 240,691 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-14 Option Award |
2025-03-17 5:16 pm |
N/A 2035-03-14 |
Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer |
451,000 | $0 | 698,245 (Direct) |
View |
| 2024-03-14 Option Award |
2024-03-15 4:32 pm |
N/A 2034-03-14 |
Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer |
370,000 | $0 | 443,936 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-15 09:21 am |
N/A 2033-03-14 |
Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer |
48,200 | $0 | 112,936 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-12 4:07 pm |
N/A 2032-12-09 |
Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer |
110,000 | $0 | 129,771 (Direct) |
View |
Ownership |
2022-11-16 4:11 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer |
0 | $0 | 19,771 (Direct) |
View |